Anti-Stress Intervention Among Physicians Study (ASIP)

April 25, 2024 updated by: Valentin Max Vetter, Charite University, Berlin, Germany

Evaluation of Easy-to-implement Anti-stress Interventions in a Series of N-of-1 Trials Among Physicians in Residence

Medical practice often comes with high stress. Stress negatively affects our health and well-being and is linked to doctors making mistakes, some of which can be deadly.

In this study, the effect of two quick stress-relief methods on daily stress levels is estimated. The two anti-stress exercises are designed to easily fit into daily routines:

  1. Box breathing (6 minutes) is known to reduce stress and lower the heart rate. It is used by the military and law enforcement, among others, to manage stress.
  2. Breathing and mindfulness exercise (10 minutes): This guided breathing and mindfulness intervention combines mindful breathing with simple body movements, developed to reduce the perceived level of stress.

The effectiveness of these interventions is being examined in a series of N-of-1 trials. Each participant can choose between the interventions. After being randomly allocated to an individual sequence of one-week intervention and control phases, the study begins. Participants record their stress levels daily over the four-week study period. The intervention is only performed in the intervention phases. Upon completing the study, the stress levels during the intervention phases are compared to those in the control phases. Each participant will receive an individual analysis based on the collected data. In addition, the investigators will estimate the effects at the population level.

Three months after the study, a survey will be sent to the participants to check if the benefits have persisted.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Berlin, Germany, 10117
        • Recruiting
        • Charité - Universitätsmedizin Berlin
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria

  • Physicians in training in Germany
  • Weekly working time in medical activity of at least 9 hours
  • Regular access to a mobile phone on which the "StudyU"-App can be installed
  • Informed consent

Exclusion criteria

  • Age <18 years
  • Specialist training already completed
  • No clinical activity during the study period or part of the study period (e.g. vacation, research activity, etc.)
  • Participation in another intervention study during the study period
  • Does not speak German
  • Does yoga more than 4 times a month
  • Meditates or performs breathing exercises on average more than 4 days per month
  • Confirmed or suspected pregnancy
  • Presence of a psychiatric disorder
  • Presence of cardiovascular disease
  • Presence of respiratory or pulmonary disease
  • Presence of a neurological disease
  • Substance abuse (for example, alcohol, drugs, or other)
  • Planned surgery within the next 6 months
  • Doctor's recommendation (or self-assessment) not to perform mindfulness or breathing exercises
  • Lack of informed consent
  • Employee of the Charité - Universitätsmedizin Berlin (due to data protection reasons, employees of the Charité - Universitätsmedizin Berlin will not be included in this study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Box Breathing
In the intervention phase of the N-of-1 trial participants are instructed to perform box breathing intervention. During the control phase of the N-of-1 trial, participants are instructed to proceed with their daily activities as usual without engaging in the anti-stress intervention.
Participants are guided to find a quite and comfortable spot to sit and unwind. They are then directed to inhale deeply for four seconds, hold that breath for another four seconds, and then exhale slowly over four seconds. Following a brief four-second pause, they begin the next cycle of breathing. To assist with this exercise, participants will have access to a video featuring a red dot tracing a square pattern, moving at the pace needed for the breathing technique.
Other Names:
  • Tactical Breathing
Participants are instructed to not perform the anti-stress intervention and to proceed with their daily activities as usual.
Experimental: Breathing and Mindfulness Exercise
In the intervention phase of the N-of-1 trial participants are instructed to perform the guided breathing and mindfulness exercise. During the control phase of the N-of-1 trial, participants are instructed to proceed with their daily activities as usual without engaging in the anti-stress intervention.
Participants are instructed to not perform the anti-stress intervention and to proceed with their daily activities as usual.
The second intervention involves a 10-minute session of guided breathing exercises that blend elements of mindfulness meditation with gentle body movements and controlled breathing. Participants are advised to find a quiet space, sit comfortably, and adopt an upright posture. They are then led through a series of brief exercises, incorporating mild stretches for the upper body and focused, mindful breathing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily perceived stress
Time Frame: daily on day 1 to day 28 of the study
Participants are asked to answer the following question on an analog scale from 1 ("not at all") to 10 ("extremely"): "Overall, how stressful was your day?"
daily on day 1 to day 28 of the study
Daily expectation of perceived stress level on the following day
Time Frame: daily on day 1 to day 28 of the study
Participants are asked to answer the following question on an analog scale from 1 ("not at all") to 10 ("extremely"): "Which level of stress do you expect for the following day?"
daily on day 1 to day 28 of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of agreement between expected and actually perceived level of stress
Time Frame: daily on day 1 to day 28 of the study
By subtracting the expected from the actually experienced level of stress, the level of agreement will be assessed.
daily on day 1 to day 28 of the study
Compliance with the study protocol: number of participant reported outcomes
Time Frame: After 4 weeks
Compliance with the study protocol will be assessed by counting the number of participant reported outcomes documented.
After 4 weeks
Compliance with the study protocol: number of performed anti-stress interventions
Time Frame: After 4 weeks
Compliance with the study protocol will be assessed by counting the number of anti-stress interventions completed over the entire duration of the study.
After 4 weeks
Successful study completion
Time Frame: After 4 weeks
Successful completion of the study will be assessed based on the minimum required number of results reported by participants during the study period to be included in the final statistical analysis.
After 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Valentin M Vetter, MD, Charite University, Berlin, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2024

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

October 30, 2024

Study Registration Dates

First Submitted

April 8, 2024

First Submitted That Met QC Criteria

April 11, 2024

First Posted (Actual)

April 16, 2024

Study Record Updates

Last Update Posted (Actual)

April 26, 2024

Last Update Submitted That Met QC Criteria

April 25, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Psychological

Clinical Trials on Box Breathing

3
Subscribe